CA2141214A1 - Hydroxamic acid derivatives and their use as anti-inflammatory compounds - Google Patents

Hydroxamic acid derivatives and their use as anti-inflammatory compounds

Info

Publication number
CA2141214A1
CA2141214A1 CA002141214A CA2141214A CA2141214A1 CA 2141214 A1 CA2141214 A1 CA 2141214A1 CA 002141214 A CA002141214 A CA 002141214A CA 2141214 A CA2141214 A CA 2141214A CA 2141214 A1 CA2141214 A1 CA 2141214A1
Authority
CA
Canada
Prior art keywords
enyl
methylprop
phenyl
cyanophenoxy
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002141214A
Other languages
English (en)
French (fr)
Inventor
Simon Teanby Hodgson
David Evan Davies
Steven Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2141214A1 publication Critical patent/CA2141214A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002141214A 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds Abandoned CA2141214A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215921A GB9215921D0 (en) 1992-07-27 1992-07-27 Anti-inflammatory compounds
GB9215921.9 1992-07-27

Publications (1)

Publication Number Publication Date
CA2141214A1 true CA2141214A1 (en) 1994-02-03

Family

ID=10719360

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002141214A Abandoned CA2141214A1 (en) 1992-07-27 1993-07-27 Hydroxamic acid derivatives and their use as anti-inflammatory compounds

Country Status (10)

Country Link
EP (1) EP0652864A1 (ko)
JP (1) JPH07509462A (ko)
AU (1) AU672810B2 (ko)
CA (1) CA2141214A1 (ko)
GB (1) GB9215921D0 (ko)
IL (1) IL106472A0 (ko)
MX (1) MX9304503A (ko)
TW (1) TW246670B (ko)
WO (1) WO1994002448A1 (ko)
ZA (1) ZA935378B (ko)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2104424T3 (es) * 1993-11-26 1997-10-01 Pfizer Compuestos de isoxazolina como agentes antiinflamatorios.
US5696141A (en) * 1994-03-09 1997-12-09 Pfizer Inc. Isoxazoline compounds as 5-lipoxygenase inhibitors
WO1996023772A1 (fr) * 1995-02-02 1996-08-08 Nikken Chemicals Co., Ltd. Derives de n-hydroxyuree
ATE210461T1 (de) 1996-02-13 2001-12-15 Searle & Co Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten
EP0880362B1 (en) 1996-02-13 2005-05-25 G.D. SEARLE & CO. Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
AU1952597A (en) 1996-02-13 1997-09-02 G.D. Searle & Co. Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor
DK0912184T3 (da) * 1996-06-25 2002-11-25 Cephalon Inc Anvendelse af K-252a-derivat til behandlingen af perifere eller centrale nervelidelser og cytokinoverproduktion
TR199903287T2 (xx) * 1997-07-31 2000-09-21 Abbott Laboratories Matriks metaloproteinazlar�n�n ters hidroksamat inhibit�rleri.
US6235786B1 (en) 1997-08-06 2001-05-22 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6294573B1 (en) 1997-08-06 2001-09-25 Abbott Laboratories Reverse hydroxamate inhibitors of matrix metalloproteinases
US6288261B1 (en) 1998-12-18 2001-09-11 Abbott Laboratories Inhibitors of matrix metalloproteinases
WO2000044712A1 (en) * 1999-01-27 2000-08-03 Abbott Laboratories N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
SE0103325D0 (sv) * 2001-10-04 2001-10-04 Astrazeneca Ab Novel compounds
TW200946105A (en) 2008-02-07 2009-11-16 Kyorin Seiyaku Kk Therapeutic agent or preventive agent for inflammatory bowel disease containing amino alcohol derivative as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU201300B (en) * 1985-03-16 1990-10-28 Wellcome Found Process for production of derivatives of aryl and medical compositions containing them as active substance
PL154186B1 (en) * 1987-07-15 1991-07-31 Wellcome Found Method for manufacturing arylic derivatives of the hydroxamic acid
WO1992001682A1 (en) * 1990-07-25 1992-02-06 Abbott Laboratories Acetylene derivatives having lipoxygenase inhibitory activity
JPH06256285A (ja) * 1990-12-11 1994-09-13 Pfizer Pharmaceut Co Ltd ヒドロキサム酸誘導体およびその用途

Also Published As

Publication number Publication date
TW246670B (ko) 1995-05-01
GB9215921D0 (en) 1992-09-09
MX9304503A (es) 1994-04-29
WO1994002448A1 (en) 1994-02-03
AU672810B2 (en) 1996-10-17
JPH07509462A (ja) 1995-10-19
ZA935378B (en) 1995-01-26
EP0652864A1 (en) 1995-05-17
IL106472A0 (en) 1993-11-15
AU4717093A (en) 1994-02-14

Similar Documents

Publication Publication Date Title
CA2141214A1 (en) Hydroxamic acid derivatives and their use as anti-inflammatory compounds
JP4495456B2 (ja) 新規の抗炎症性アンドロスタン誘導体
US7160920B2 (en) Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
AU2011252337C1 (en) New cyclohexylamine derivatives having beta2 adrenergic agonist and M3 muscarinic antagonist activities
AU727900B2 (en) Benzamidine derivatives and their use as medicaments with an LTB4-antagonistic activity
HUT64514A (en) Process for producing arylic comdounds with anti-atherosclerotic effect
EA005992B1 (ru) S-ФТОРМЕТИЛОВЫЙ ЭФИР 6α,9α-ДИФТОР-17α-[(2-ФУРАНИЛКАРБОНИЛ)ОКСИ]-11β-ГИДРОКСИ-16α-МЕТИЛ-3-ОКСОАНДРОСТА-1,4-ДИЕН-17β-КАРБОТИОКИСЛОТЫ В КАЧЕСТВЕ ПРОТИВОВОСПАЛИТЕЛЬНОГО АГЕНТА
JP2008543825A (ja) Ｎ−（ピリジン−２−イル）−スルホンアミド誘導体
JPH057386B2 (ko)
HU224823B1 (en) Substituted benzamidines,process for preparing the said compds. and pharmaceutical compns. contg. them
US5010093A (en) Nitric ester derivative
US4857301A (en) Sulfonamide compounds, compositions and method of use
PT89118B (pt) Processo para a preparacao de derivados de anilina e de composicoes farmaceuticas que os contem
JP7340023B2 (ja) テトラゾロン置換ステロイド及びその使用
ES2324209T3 (es) 2-(3,5-bis-trifluormetil-fenil)-n-(6-(1,1-dioxo-1lambda6-tiomorfolin-4-il)-4-(2-metil o 4-fluor-2-metil substituido)fenil-piridin-3-il)-n-metil-isobutiramida.
KR100416674B1 (ko) 크로몬유도체
AP454A (en) Therapeutic compounds with hydroxamic acid derivatives.
EP0247201B1 (en) Propane-1,3-diol derivatives, a method for their production and a pharmaceutical composition
JP2003530381A (ja) 化合物
JPH0451554B2 (ko)
JPH07165739A (ja) ２，２−二置換グリセロールおよびグリセロール類似化合物
JPH08509487A (ja) シクロオキシゲナーゼ及び５−リポキシゲナーゼを阻害するヒドロキサム酸誘導体
BE897763A (fr) Sel de l'acide piperidinyl-cyclopentanol heptenoique
JPS63227579A (ja) アルフア−メルカプトメチルベンゼンプロパンアミドの新規なｎ‐置換誘導体、それらの製造法、薬剤としての用途及びそれを含有する組成物
CZ215992A3 (cs) Nové acylaminohetrazepinové deriváty, způsob výroby a farmaceutické prostředky sjejích obsahem

Legal Events

Date Code Title Description
FZDE Discontinued